Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: CAExchange: Nasdaq
DilutionScan read 25 of NERVGEN PHARMA CORP.'s SEC filings and found 5 warrant series, 2 ATM programs, 2 shelf registrations and 2 completed offerings on file for NGEN. The latest dilution event on file is ATM sales on Jul 2, 2026. Analysis updated Oct 16, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
TARAProtara Therapeutics, Inc.
CUECue Biopharma, Inc.
MXCTMaxCyte, Inc.
VRXAVeraxa Biotech AG Ordinary Shares
CMPXCompass Therapeutics, Inc.
MSLESatellos Bioscience Inc.
MGNXMacroGenics, Inc.
MENSJyong Biotech Ltd. Ordinary Shares
MOLNMolecular Partners AG American Depositary Shares
IPHAInnate Pharma S.A. ADS
STROSutro Biopharma, Inc.
CNTNCanton Strategic Holdings Inc
PDSBPDS Biotechnology Corporation
FHTXFoghorn Therapeutics Inc.
SPRBSpruce Biosciences, Inc.